159 related articles for article (PubMed ID: 11990782)
1. P glycoprotein and the mechanism of multidrug resistance.
Váradi A; Szakács G; Bakos E; Sarkadi B
Novartis Found Symp; 2002; 243():54-65; discussion 65-8, 180-5. PubMed ID: 11990782
[TBL] [Abstract][Full Text] [Related]
2. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
[TBL] [Abstract][Full Text] [Related]
3. The catalytic cycle of P-glycoprotein.
Senior AE; al-Shawi MK; Urbatsch IL
FEBS Lett; 1995 Dec; 377(3):285-9. PubMed ID: 8549739
[TBL] [Abstract][Full Text] [Related]
4. Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein.
Konings WN; Poelarends GJ
IUBMB Life; 2002; 53(4-5):213-8. PubMed ID: 12120998
[TBL] [Abstract][Full Text] [Related]
5. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
Liu R; Sharom FJ
Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
[TBL] [Abstract][Full Text] [Related]
6. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
[TBL] [Abstract][Full Text] [Related]
7. A molecular understanding of the catalytic cycle of the nucleotide-binding domain of the ABC transporter HlyB.
Zaitseva J; Jenewein S; Oswald C; Jumpertz T; Holland IB; Schmitt L
Biochem Soc Trans; 2005 Nov; 33(Pt 5):990-5. PubMed ID: 16246029
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of P-glycoprotein ATPase by analogues of tetramethylrosamine: coupling of drug binding at the "R" site to the ATP hydrolysis transition state.
Tombline G; Donnelly DJ; Holt JJ; You Y; Ye M; Gannon MK; Nygren CL; Detty MR
Biochemistry; 2006 Jul; 45(26):8034-47. PubMed ID: 16800628
[TBL] [Abstract][Full Text] [Related]
9. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
Ramachandra M; Ambudkar SV; Chen D; Hrycyna CA; Dey S; Gottesman MM; Pastan I
Biochemistry; 1998 Apr; 37(14):5010-9. PubMed ID: 9538020
[TBL] [Abstract][Full Text] [Related]
10. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.
Qu Q; Russell PL; Sharom FJ
Biochemistry; 2003 Feb; 42(4):1170-7. PubMed ID: 12549939
[TBL] [Abstract][Full Text] [Related]
11. Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study.
Liu R; Sharom FJ
Biochemistry; 1998 May; 37(18):6503-12. PubMed ID: 9572868
[TBL] [Abstract][Full Text] [Related]
12. Predicting the three-dimensional structure of human P-glycoprotein in absence of ATP by computational techniques embodying crosslinking data: insight into the mechanism of ligand migration and binding sites.
Vandevuer S; Van Bambeke F; Tulkens PM; Prévost M
Proteins; 2006 May; 63(3):466-78. PubMed ID: 16463278
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein: from genomics to mechanism.
Ambudkar SV; Kimchi-Sarfaty C; Sauna ZE; Gottesman MM
Oncogene; 2003 Oct; 22(47):7468-85. PubMed ID: 14576852
[TBL] [Abstract][Full Text] [Related]
14. The power of the pump: mechanisms of action of P-glycoprotein (ABCB1).
Ambudkar SV; Kim IW; Sauna ZE
Eur J Pharm Sci; 2006 Apr; 27(5):392-400. PubMed ID: 16352426
[TBL] [Abstract][Full Text] [Related]
15. ATP hydrolysis promotes interactions between the extracellular ends of transmembrane segments 1 and 11 of human multidrug resistance P-glycoprotein.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2005 Aug; 44(30):10250-8. PubMed ID: 16042402
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2007 Aug; 46(32):9328-36. PubMed ID: 17636884
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.
Liu R; Sharom FJ
Biochemistry; 1997 Mar; 36(10):2836-43. PubMed ID: 9062112
[TBL] [Abstract][Full Text] [Related]
18. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
Rao US
Biochemistry; 1998 Oct; 37(42):14981-8. PubMed ID: 9778376
[TBL] [Abstract][Full Text] [Related]
19. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism.
van Veen HW; Margolles A; Müller M; Higgins CF; Konings WN
EMBO J; 2000 Jun; 19(11):2503-14. PubMed ID: 10835349
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the "occluded nucleotide conformation" of P-glycoprotein in the catalytic pathway.
Tombline G; Muharemagić A; White LB; Senior AE
Biochemistry; 2005 Sep; 44(38):12879-86. PubMed ID: 16171403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
